Watchlist Price Alert

Pacira BioSciences Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

24.50

0.27 (1.11%)

At close: Jun 23, 2025, 10:58 AM

Dividends

No dividend history available for Pacira BioSciences Inc..

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield
Dr. Reddy's Laboratories	0.59%
Phibro Animal Health	2%

Dividend Rankings

PCRX News

4 days ago · Is the Options Market Predicting a Spike in Pacira BioSciences Stock? - zacks.com
2 weeks ago · Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
4 weeks ago · Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Reach Out - accessnewswire.com
1 month ago · Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Shareholders to Inquire about Securities Investigation - accessnewswire.com
1 month ago · Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRA) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
1 month ago · Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates - zacks.com
1 month ago · Pacira BioSciences, Inc. (PCRX) Q1 2025 Earnings Call Transcript - seekingalpha.com
1 month ago · Pacira (PCRX) Q1 Earnings Surpass Estimates - zacks.com
1 month ago · 5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates - zacks.com
2 months ago · Why Pacira (PCRX) is Poised to Beat Earnings Estimates Again - zacks.com